PharmaSpotter
SearchVendors
HomeSearchOracle Corporation (Oracle Life Sciences)
Oracle Corporation (Oracle Life Sciences) logo

Oracle Corporation (Oracle Life Sciences)

"Oracle Life Sciences — applications and infrastructure for clinical, safety, and real-world data"

Public$NYSE: ORCL
Visit Website

Founded

1977

49 years

Employees

1001-5000

Annual Revenue

Not Disclosed

(2026)

Products

1

Company Overview

This vendor profile is scoped to Oracle's Life Sciences division — formerly Oracle Health Sciences, renamed Oracle Life Sciences — which houses the Argus Safety / Safety One Argus pharmacovigilance platform alongside clinical-trial systems and real-world data products. Oracle Corporation is a publicly traded (NYSE: ORCL) multinational headquartered in Austin, Texas (formerly Redwood Shores, California).

Oracle entered the pharmacovigilance market through the 2004 acquisition of Relsys, the original developer of Argus. Oracle has been progressively retrofitting the platform since: IE-only client replaced with Chrome/Edge compatibility in 8.2.3 (April 2021); Oracle Cloud Service ("Argus Cloud") on OCI; AI-based intake module ("Safety One Intake," now "Consolidated Intake") reached GA as 24.1 in June 2024; OCI Language translation in 30 languages announced October 2024; OCI Generative AI narrative-generation hooks in 8.4.4 cloud admin documentation; 2026.1.01 release renamed the suite "Safety One Argus."

Oracle states Argus processes >10M cases annually across 400+ customers globally, accounting for ~70% of FDA FAERS ICSRs. EVERSANA is Oracle's promoted global implementation partner. The named systems-integrator ecosystem includes Cognizant, Accenture, TCS, Wipro, Indegene, NNIT, Saama, Quanticate, Daelight, Techsol, Gratisol, Ultragenic, Perficient, PrimeVigilance, and QPS.

Pharmaceutical Focus

Oracle Life Sciences is pharma-specialised, serving top-20 pharma, biotech, and pharmacovigilance CROs. The Argus customer base is enterprise-only: third-party customer-base analysis reports zero recorded users in the 0–1,000-employee band and 100% concentration in organisations of 1,001–10,000+ employees. Oracle states Argus processes >10M cases per year in aggregate across Argus Cloud, accounting for ~70% of FDA FAERS ICSRs, with a majority of top-20 pharmaceutical companies historically using Argus; Oracle does not publish a named top-20 list.

Named customers from Oracle press releases and partner case studies include EVERSANA, LSK Global Pharma Services (Korea CRO), PrimeVigilance (Ergomed Group, 41+ enterprise clients on a consolidated Argus platform), QPS Holdings, CSL Behring, Ipca Laboratories (India), Daewoong Pharmaceutical (Korea), Hugel (Korea, on Argus 7.0.4.1 via Techsol), and UBC. Argus Safety Japan supports PMDA J-DIA and MedDRA-J with split global/Japan workflows, for organisations with Japan operations. Oracle Life Sciences also serves clinical-trial and real-world-data customers; these sit outside Argus's scope.

Industries Served

PharmaceuticalsBiotechnologyLife Sciences
Financial Overview

Oracle Corporation reports FY revenues in the tens of billions of dollars, publicly traded on NYSE (ORCL), with cloud infrastructure (OCI) and applications, including Life Sciences, as reported growth segments. Argus pricing is undisclosed. Reported deal sizes from third-party practitioner sources range from a $150K+ floor for small-pharma/biotech subscriptions to $2M–$5M+ for top-20 multi-region deployments. Oracle claims a TCO reduction of more than 50% for customers migrating from on-premise to Argus Cloud on OCI. M&A relevant to PV scope: the 2004 acquisition of Relsys brought Oracle Argus, and Phase Forward (clinical) was acquired earlier in the 2000s. EVERSANA was promoted to Oracle Partner Network status for PV in 2023.

Products from Oracle Corporation (Oracle Life Sciences)

Browse all software products offered by Oracle Corporation (Oracle Life Sciences).

Oracle Argus Safety (Oracle Life Sciences Safety One Argus)
Pharmacovigilance

Enterprise pharmacovigilance database — available either as Windows/Oracle DB on-premise or as Oracle-hosted Cloud Service on OCI — used by pharma and CRO PV teams to intake, MedDRA-code, assess, and submit ICSRs to global regulators in E2B(R2)/E2B(R3). Oracle states Argus processes more than 10 million cases annually and accounts for ~70% of ICSRs in FDA FAERS.

FDA Part 11GxP
Products & Solutions

Argus product family: Argus Safety (operator UI and workflow), Argus Interchange (E2B inbound/outbound gateway), Argus Affiliate (local-affiliate views with country-specific workflows), Argus Unblinding (separation-of-duty workflow for blinded clinical reporting), Argus Dossier (aggregate reports), Argus Mart and Argus Insight (warehouse and analytical reporting), Argus Analytics (OBIEE-based dashboards), Argus Safety Japan, and the Empirica family (signal detection, sold separately).

Editions: Argus Standard Edition (core case processing), Argus Enterprise Edition (Standard + Insight + Mart + Analytics + Dossier), Argus Safety Japan, Oracle Argus Cloud Service (Standard and Advanced tiers — Advanced bundles Oracle Analytics), Safety One Intake / Consolidated Intake (AI add-on for source-document extraction), Empirica Signal / Topics / Study (separate signal-detection products).

AI / ML roadmap: Safety One Intake (24.1 GA June 2024); OCI Language translation in 30 languages for Argus narrative fields (Oct 2024); OCI Generative AI narrative-generation hooks in the 8.4.4 Cloud Admin Guide; Oracle Analytics AI in Argus Advanced. Oracle delivers these AI capabilities as OCI add-ons rather than as embedded agentic features within the case-processing workflow. Oracle Life Sciences also offers clinical (formerly InForm, Siebel Clinical), real-world data, and Health Data Intelligence products, outside the Argus / safety scope.

Partnerships & Technology

Hosted on Oracle Cloud Infrastructure (OCI). Major SI partners with public Argus practices: Cognizant, Accenture, TCS (Tata), Wipro, Indegene (acquired Sciformix), NNIT, Saama, Quanticate, Daelight, Techsol Life Sciences, Gratisol, Ultragenic, Perficient, EVERSANA (promoted to Oracle Partner Network status for PV in 2023, now positioned as global implementation partner), PrimeVigilance, QPS. E2B gateway partners: Oracle B2B and Axway. AI infrastructure: OCI Language, OCI Generative AI, Oracle Analytics. Industry affiliations: ICH (E2A/E2B(R2)/E2B(R3)/E2C/E2D), EMA EudraVigilance gateway, MedDRA / MedDRA-J, WHODrug. Tier-1 SI ecosystem is mature and operates Argus end-to-end for many customers via managed services.

Technology Partners

Oracle
Support & Services

Oracle Argus Cloud Service subscription includes infrastructure, platform, and application management (deployment, upgrading, patching), delivered as "Application Management Services (AMS)," plus optional dictionary recoding services. Validation, configuration, data migration, integration, SOP development, and training are priced separately. Many top-20 customers run Argus exclusively via SI managed services rather than in-house, with annual managed-service contracts reported in the $500K–$3M+ range depending on case volume and number of affiliates.

Support tiers and SLA specifics are undisclosed for Argus; Oracle Premier Support typically applies. SI partners (Techsol, Gratisol) market "validation accelerators" claiming 50–70% time and effort reduction. Oracle historically ran the Oracle Health Sciences User Group; Argus-specific user-group cadence is undisclosed.

Validation
Training
Credibility & Recognition

Analyst recognition: Oracle named a Leader in the IDC MarketScape: Worldwide Life Science R&D Pharmacovigilance Technology Solutions and Consulting Services 2025 Vendor Assessment (doc # US53669225, July 2025). Oracle holds no dedicated PV-software Gartner Magic Quadrant or Forrester Wave recognition. OCI infrastructure carries multiple ISO/SOC attestations; no Argus-specific SOC 2 Type II or ISO 27001 report is published.

Leadership: undisclosed at the Life Sciences division level. Thought leadership: Oracle press cadence on Argus features (AI translation Oct 2024, EVERSANA partnership Oct 2024, LSK Global Mar 2025, PrimeVigilance Jul 2025), release notes, and admin documentation.

Market Presence

Oracle runs an active press cadence via oracle.com/news, covering Argus customer wins (EVERSANA Oct 2024, LSK Global Mar 2025, PrimeVigilance Jul 2025) and feature launches (AI translation Oct 2024, Safety One Intake GA June 2024, OCI GenAI narrative hooks), alongside a documentation portal at docs.oracle.com/en/industries/life-sciences/. Customer-facing marketing has consolidated under the rebrand to Oracle Life Sciences (formerly Oracle Health Sciences). Presence at PV industry events (DIA, ISoP, BioJapan) is inferred through SI partner activity.

Oracle continues to modernise Argus in place through OCI cloud delivery and OCI AI services, rather than rebuilding it cloud-native.

Company Details

Headquarters

Austin, Texas, United States

Founded

1977 (49 years in business)

Company Size

1001-5000 employees

Type

Public

Owned by Not applicable - independent public company

Annual Revenue

Not Disclosed (2026)

Stock Ticker

$NYSE: ORCL
FDA-Compliant Solutions
Community Contributed
No Sponsored Rankings
Updated Weekly

PharmaSpotter

Comprehensive directory of pharmaceutical software solutions. QMS, LIMS, MES, analytics, and compliance tools for FDA-regulated manufacturing environments.

22 Solution Categories•Curated Data

Software Categories

  • Quality Management Systems
  • Manufacturing Execution Systems
  • Lab Information Management
  • Electronic Batch Records
  • CAPA & Deviation Management
  • Change Control
  • View All Categories →

Resources

  • RFP Template
  • Vendor Scorecard
  • Compliance Guide
  • Implementation Timeline
  • Contribute Data
© 2025 PharmaSpotter. All rights reserved.
Curated pharmaceutical software directory for FDA-regulated manufacturing environments
AboutContactContribute•Privacy PolicyTermsDisclaimer